Skip to main content
. 2017 Jun 29;16(3):2595–2603. doi: 10.3892/mmr.2017.6879

Figure 3.

Figure 3.

Cell proliferation was compared between LO2 normal liver cells and HepG2 liver cancer cells following treatment with 50 µg/ml YS206 or YS306 for 24 h. *P<0.05; **P<0.01.